2014 CRO Leadership Awards Winner
Categories Won:
-
Quality
Drug Life Cycle Stages:
- Research & Development: Clinical (Phase 1, Phase 2, Phase 3)
- Formulated Drug Production: Logistics
Main Service Areas:
Bioanalytical, Clinical
Services & Capabilities:
PRA provides comprehensive clinical trial and strategic/embedded staffing services across all phases. We also offer integrated bioanalytical laboratories, on-site pharmacies, and clinical facilities in both Europe and North America.
Therapeutic Areas:
Neurosciences (CNS), oncology/hematology, infectious diseases, cardiometabolic, psychiatry, respiratory, genitourinary, endocrinology, gastroenterology, immunology, hepatology, dermatology, biosimilar products, cardio-metabolic diseases, and rare diseases
Colin Shannonpresident and CEO“Quality is the single most important element in PRA . Quality is deeply ingrained in every PRA process and every system. It is our devoted PRA colleagues that drive quality throughout the company as we continuously challenge ourselves to improve and innovate. PRA is dedicated to work in close partnership with emerging biotech companies to successfully bring powerful new lifesaving medicines and devices to the patients who need them.” |